Nearly 5,000 people are reported dead because of infected A-H1N1 virus, or swine flu infections since it emerged this year and spread into a global pandemic. Reported the world's health agency (WHO), Friday (23/10) in Geneva, Switzerland.
WHO says, the number would the death toll may be higher than these reports, because many countries stopped counting cases of swine flu infection. Countries that report that the victim died from the virus for the first time is Iceland, Sudan, Trinidad and Tobago.
In London, England, vaccine manufacturers GlaxoSmithKline PLC said, one dose of vaccine is sufficient to protect children from H1N1 virus infection. In a statement, Glaxo said, one dose of vaccine is sufficient to increase the child's immune system to fight the virus. This is based on research conducted in Spain on 200 children aged six months to three years.
The statement was issued to refute the opinion of experts who say that children need two doses of the vaccine because their immune systems are weaker than adults.
Pandemrix GlaxoSmithKline vaccine containing adjuvant production, the chemical that strengthens the active ingredients of vaccines and increase the body's immune system response. Although most of the flu vaccine in Europe in general contain adjuvant, but not a lot of data that prove the safety of a group of children and pregnant women.
Adjuvant alone was used by Glaxo flu vaccine products and already used by 41,000 people in the face of transmission of bird flu, swine flu, and common influenza.
WHO says, the number would the death toll may be higher than these reports, because many countries stopped counting cases of swine flu infection. Countries that report that the victim died from the virus for the first time is Iceland, Sudan, Trinidad and Tobago.
In London, England, vaccine manufacturers GlaxoSmithKline PLC said, one dose of vaccine is sufficient to protect children from H1N1 virus infection. In a statement, Glaxo said, one dose of vaccine is sufficient to increase the child's immune system to fight the virus. This is based on research conducted in Spain on 200 children aged six months to three years.
The statement was issued to refute the opinion of experts who say that children need two doses of the vaccine because their immune systems are weaker than adults.
Pandemrix GlaxoSmithKline vaccine containing adjuvant production, the chemical that strengthens the active ingredients of vaccines and increase the body's immune system response. Although most of the flu vaccine in Europe in general contain adjuvant, but not a lot of data that prove the safety of a group of children and pregnant women.
Adjuvant alone was used by Glaxo flu vaccine products and already used by 41,000 people in the face of transmission of bird flu, swine flu, and common influenza.
Posts
No comments:
Post a Comment